Onco-miR-130 promotes cell proliferation and migration by targeting TGFβR2 in gastric cancer

Oncotarget

Volumn 7, Issue 28, 2016, Pages 44522-44533

  Duan, Jingjing ^a   Zhang, Haiyang ^a   Qu, Yanjun ^a   Deng, Ting ^a   Huang, Dingzhi ^a   Liu, Rui ^a   Zhang, Le ^a   Bai, Ming ^a   Zhou, Likun ^a   Ying, Guoguang ^a   Ba, Yi ^a  

^a TIANJIN MEDICAL UNIVERSITY   (China)

Author keywords

Gastric cancer; Migration; MiR 130; Proliferation; TGF R2

Indexed keywords

FIREFLY LUCIFERASE; MEMBRANE PROTEIN; MESSENGER RNA; MICRORNA; MICRORNA 130; SMALL INTERFERING RNA; TRANSFORMING GROWTH FACTOR BETA RECEPTOR 2; UNCLASSIFIED DRUG; MIRN130 MICRORNA, HUMAN; PROTEIN SERINE THREONINE KINASE; TRANSFORMING GROWTH FACTOR BETA RECEPTOR; TRANSFORMING GROWTH FACTOR-BETA TYPE II RECEPTOR;

3' UNTRANSLATED REGION; ARTICLE; CANCER INCIDENCE; CANCER PATIENT; CANCER PROGNOSIS; CARCINOGENESIS; CELL GROWTH; CELL MIGRATION; CELL PROLIFERATION; CONTROLLED STUDY; DNA MODIFICATION; DOWN REGULATION; EPIGENETICS; EPITHELIAL MESENCHYMAL TRANSITION; GASTRECTOMY; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; METASTASIS; ONCOGENE; PHENOTYPE; PORCINE REPRODUCTIVE AND RESPIRATORY SYNDROME VIRUS; PROTEIN PHOSPHORYLATION; QUANTITATIVE ANALYSIS; STOMACH CANCER; TUMOR GROWTH; VIRUS REPLICATION; WESTERN BLOTTING; CELL MOTION; GENE EXPRESSION REGULATION; GENETICS; METABOLISM; PATHOLOGY; RNA INTERFERENCE; STOMACH TUMOR; TUMOR CELL LINE; UPREGULATION;

3' UNTRANSLATED REGIONS; CELL LINE, TUMOR; CELL MOVEMENT; CELL PROLIFERATION; EPITHELIAL-MESENCHYMAL TRANSITION; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MICRORNAS; ONCOGENES; PROTEIN-SERINE-THREONINE KINASES; RECEPTORS, TRANSFORMING GROWTH FACTOR BETA; RNA INTERFERENCE; RNA, MESSENGER; STOMACH NEOPLASMS; UP-REGULATION;

EID: 84978634439     PISSN: None     EISSN: 19492553     Source Type: Journal    
DOI: 10.18632/oncotarget.9936     Document Type: Article

References (36)

1. Ferro A, Peleteiro B, Malvezzi M, Bosetti C, Bertuccio P, Levi F, Negri E, La Vecchia C and Lunet N. Worldwide trends in gastric cancer mortality (1980-2011), with predictions to 2015, and incidence by subtype. European journal of cancer (Oxford, England: 1990). 2014; 50:1330-1344.
2. Power DG, Kelsen DP and Shah MA. Advanced gastric cancer-slow but steady progress. Cancer treatment reviews. 2010; 36:384-392.
3. Hohenberger P and Gretschel S. Gastric cancer. Lancet. 2003; 362:305-315.
4. Moustakas A and Heldin CH. The regulation of TGFbeta signal transduction. Development (Cambridge, England). 2009; 136:3699-3714.
5. Alejandre-Alcazar MA, Kwapiszewska G, Reiss I, Amarie OV, Marsh LM, Sevilla-Perez J, Wygrecka M, Eul B, Kobrich S, Hesse M, Schermuly RT, Seeger W, Eickelberg O and Morty RE. Hyperoxia modulates TGF-beta/BMP signaling in a mouse model of bronchopulmonary dysplasia. American journal of physiology Lung cellular and molecular physiology. 2007; 292:L537-549.
6. Sureshbabu A, Syed MA, Boddupalli CS, Dhodapkar MV, Homer RJ, Minoo P and Bhandari V. Conditional overexpression of TGFbeta1 promotes pulmonary inflammation, apoptosis and mortality via TGFbetaR2 in the developing mouse lung. Respiratory research. 2015; 16:4.
7. Han Y, Jia C, Cong X, Yu F, Cai H, Fang S, Cai L, Yang H, Sun Y, Li D, Liu J, Xie R, Yuan X, Zhong X, Li M, Wei Q, et al. Increased Expression of TGFbetaR2 Is Associated with the Clinical Outcome of Non-Small Cell Lung Cancer Patients Treated with Chemotherapy. PloS one. 2015; 10:e0134682.
8. Haj-Salem I, Fakhfakh R, Berube JC, Jacques E, Plante S, Simard MJ, Bosse Y and Chakir J. MicroRNA-19a enhances proliferation of bronchial epithelial cells by targeting TGFbetaR2 gene in severe asthma. Allergy. 2015; 70:212-219.
9. Meulmeester E and Ten Dijke P. The dynamic roles of TGF-beta in cancer. The Journal of pathology. 2011; 223:205-218.
10. Yang L, Pang Y and Moses HL. TGF-beta and immune cells: an important regulatory axis in the tumor microenvironment and progression. Trends in immunology. 2010; 31:220-227.
11. Levy L and Hill CS. Alterations in components of the TGFbeta superfamily signaling pathways in human cancer. Cytokine & growth factor reviews. 2006; 17:41-58.
12. OstapoffKT, Cenik BK, Wang M, Ye R, Xu X, Nugent D, Hagopian MM, Topalovski M, Rivera LB, Carroll KD and Brekken RA. Neutralizing murine TGFbetaR2 promotes a differentiated tumor cell phenotype and inhibits pancreatic cancer metastasis. Cancer research. 2014; 74:4996-5007.
13. Zhang W, Zeng Z, Fan S, Wang J, Yang J, Zhou Y, Li X, Huang D, Liang F, Wu M, Tang K, Cao L, Li X, Xiong W and Li G. Evaluation of the prognostic value of TGFbeta superfamily type I receptor and TGF-beta type II receptor expression in nasopharyngeal carcinoma using high-throughput tissue microarrays. Journal of molecular histology. 2012; 43:297-306.
14. Yu Y, Kanwar SS, Patel BB, Oh PS, Nautiyal J, Sarkar FH and Majumdar AP. MicroRNA-21 induces stemness by downregulating transforming growth factor beta receptor 2 (TGFbetaR2) in colon cancer cells. Carcinogenesis. 2012; 33:68-76.
15. Mishra S, Deng JJ, Gowda PS, Rao MK, Lin CL, Chen CL, Huang T and Sun LZ. Androgen receptor and microRNA-21 axis downregulates transforming growth factor beta receptor II (TGFBR2) expression in prostate cancer. Oncogene. 2014; 33:4097-4106.
16. Reinhart BJ, Slack FJ, Basson M, Pasquinelli AE, Bettinger JC, Rougvie AE, Horvitz HR and Ruvkun G. The 21-nucleotide let-7 RNA regulates developmental timing in Caenorhabditis elegans. Nature. 2000; 403:901-906.
17. Machida T, Tomofuji T, Ekuni D, Maruyama T, Yoneda T, Kawabata Y, Mizuno H, Miyai H, Kunitomo M and Morita M. MicroRNAs in Salivary Exosome as Potential Biomarkers of Aging. International journal of molecular sciences. 2015; 16:21294-21309.
18. Schickel R, Boyerinas B, Park SM and Peter ME. MicroRNAs: key players in the immune system, differentiation, tumorigenesis and cell death. Oncogene. 2008; 27:5959-5974.
19. Bartel DP. MicroRNAs: genomics, biogenesis, mechanism, and function. Cell. 2004; 116:281-297.
20. Liu R, Chen X, Du Y, Yao W, Shen L, Wang C, Hu Z, Zhuang R, Ning G, Zhang C, Yuan Y, Li Z, Zen K, Ba Y and Zhang CY. Serum microRNA expression profile as a biomarker in the diagnosis and prognosis of pancreatic cancer. Clinical chemistry. 2012; 58:610-618.
21. Liu R, Zhang C, Hu Z, Li G, Wang C, Yang C, Huang D, Chen X, Zhang H, Zhuang R, Deng T, Liu H, Yin J, Wang S, Zen K, Ba Y, et al. A five-microRNA signature identified from genome-wide serum microRNA expression profiling serves as a fingerprint for gastric cancer diagnosis. European journal of cancer (Oxford, England: 1990). 2011; 47:784-791.
22. Liu Y, Zhao L, Li D, Yin Y, Zhang CY, Li J and Zhang Y. Microvesicle-delivery miR-150 promotes tumorigenesis by up-regulating VEGF, and the neutralization of miR-150 attenuate tumor development. Protein & cell. 2013; 4:932-941.
23. Li L, Gao F, Jiang Y, Yu L, Zhou Y, Zheng H, Tong W, Yang S, Xia T, Qu Z and Tong G. Cellular miR-130b inhibits replication of porcine reproductive and respiratory syndrome virus in vitro and in vivo. Scientific reports. 2015; 5:17010.
24. Bertero T, Cottrill KA, Lu Y, Haeger CM, Dieffenbach P, Annis S, Hale A, Bhat B, Kaimal V, Zhang YY, Graham BB, Kumar R, Saggar R, Saggar R, Wallace WD, Ross DJ, et al. Matrix Remodeling Promotes Pulmonary Hypertension through Feedback Mechanoactivation of the YAP/TAZmiR-130/301 Circuit. Cell reports. 2015; 13:1016-1032.
25. Liu R, Zhang H, Wang X, Zhou L, Li H, Deng T, Qu Y, Duan J, Bai M, Ge S, Ning T, Zhang L, Huang D and Ba Y. The miR-24-Bim pathway promotes tumor growth and angiogenesis in pancreatic carcinoma. Oncotarget. 2015; 6:43831-43842. doi: 10.18632/oncotarget.6257.
26. Li YQ, Lu JH, Bao XM, Wang XF, Wu JH and Hong WQ. MiR-24 functions as a tumor suppressor in nasopharyngeal carcinoma through targeting FSCN1. J Exp Clin Cancer Res. 2015; 34:130.
27. Zheng Y, Lv X, Wang X, Wang B, Shao X, Huang Y, Shi L, Chen Z, Huang J and Huang P. miR-181b promotes chemoresistance in breast cancer by regulating Bim expression. Oncology reports. 2015.
28. Xu CC, Wu LM, Sun W, Zhang N, Chen WS and Fu XN. Effects of TGF-beta signaling blockade on human A549 lung adenocarcinoma cell lines. Molecular medicine reports. 2011; 4:1007-1015.
29. Ma ZL, Hou PP, Li YL, Wang DT, Yuan TW, Wei JL, Zhao BT, Lou JT, Zhao XT, Jin Y and Jin YX. MicroRNA-34a inhibits the proliferation and promotes the apoptosis of non-small cell lung cancer H1299 cell line by targeting TGFbetaR2. Tumour Biol. 2015; 36:2481-2490.
30. Wang C, Hu J, Lu M, Gu H, Zhou X, Chen X, Zen K, Zhang CY, Zhang T, Ge J, Wang J and Zhang C. A panel of five serum miRNAs as a potential diagnostic tool for earlystage renal cell carcinoma. Scientific reports. 2015; 5:7610.
31. Luo Y, Wang C, Chen X, Zhong T, Cai X, Chen S, Shi Y, Hu J, Guan X, Xia Z, Wang J, Zen K, Zhang CY and Zhang C. Increased serum and urinary microRNAs in children with idiopathic nephrotic syndrome. Clinical chemistry. 2013; 59:658-666.
32. Long J, Ji Z, Jiang K, Wang Z and Meng G. miR-193b Modulates Resistance to Doxorubicin in Human Breast Cancer Cells by Downregulating MCL-1. BioMed research international. 2015; 2015:373574.
33. Li F, Xu Y, Deng S, Li Z, Zou D, Yi S, Sui W, Hao M and Qiu L. MicroRNA-15a/16-1 cluster located at chromosome 13q14 is down-regulated but displays different expression pattern and prognostic significance in multiple myeloma. Oncotarget. 2015; 6:38270-38282. doi: 10.18632/oncotarget.5681.
34. De Mattos-Arruda L, Bottai G, Nuciforo PG, Di Tommaso L, Giovannetti E, Peg V, Losurdo A, Perez-Garcia J, Masci G, Corsi F, Cortes J, Seoane J, Calin GA and Santarpia L. MicroRNA-21 links epithelial-to-mesenchymal transition and inflammatory signals to confer resistance to neoadjuvant trastuzumab and chemotherapy in HER2-positive breast cancer patients. Oncotarget. 2015; 6:37269-37280 doi: 10.18632/oncotarget.5495.
35. Pan S, Yang X, Jia Y, Li Y, Chen R, Wang M, Cai D and Zhao R. Intravenous injection of microvesicle-delivery miR-130b alleviates high-fat diet-induced obesity in C57BL/6 mice through translational repression of PPARgamma. Journal of biomedical science. 2015; 22:86.
36. Li J, Zhang Y, Liu Y, Dai X, Li W, Cai X, Yin Y, Wang Q, Xue Y, Wang C, Li D, Hou D, Jiang X, Zhang J, Zen K, Chen X, et al. Microvesicle-mediated transfer of microRNA-150 from monocytes to endothelial cells promotes angiogenesis. The Journal of biological chemistry. 2013; 288:23586-23596.